Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

29 sept. 2025 08h56 HE | Source: Research and Markets

Allergy Treatment Global Forecast Report 2025: Market to Grow by Over $20 Billion by 2033, Driven by by Accelerated Illness Prevalence, Climate-driven Allergy Amplification, and Innovative Biologics

Dublin, Sept. 29, 2025 (GLOBE NEWSWIRE) -- The "Allergy Treatment Global Market Report by Type, Treatment, Dosage Form, Distribution Channel, Countries and Company Analysis, 2025-2033" report has...
29 sept. 2025 04h04 HE | Source: Research and Markets

Systemic Mastocytosis Market Analysis and Forecast, 2025-2035 | Precision Medicine Gains Momentum as KIT D816V Mutation Detection Advances

Dublin, Sept. 29, 2025 (GLOBE NEWSWIRE) -- The "Systemic Mastocytosis Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035" report has been added...
10 sept. 2025 11h46 HE | Source: Asthma and Allergy Foundation of America

AAFA Bill to Require Allergen Labeling in Restaurants Passes in California

Washington, DC, Sept. 10, 2025 (GLOBE NEWSWIRE) -- The Asthma and Allergy Foundation of America (AAFA) issued the following statement on news that the California Assembly and Senate passed SB 68 –...
08 sept. 2025 06h30 HE | Source: Regeneron Pharmaceuticals, Inc.

Regeneron Advances Allergy Pipeline with Two Positive Phase 3 Trials Evaluating First-in-Class Antibody-Blockers of Cat and Birch Allergies

In separate cat and birch allergen-challenge trials, single doses of allergen-specific antibody blockers significantly reduced allergy symptoms compared to placebo Data from these trials will support...
15 août 2025 03h00 HE | Source: European Academy of Allergy and Clinical Immunology

EAACI Launches Global Antibiotic Allergy Awareness Campaign at EAACI Congress 2025

ZURICH, Aug. 15, 2025 (GLOBE NEWSWIRE) -- EAACI has launched its Antibiotic Allergy Awareness Campaign during its 2025 Congress in Glasgow. The initiative begins a global effort to address...
21 juil. 2025 06h25 HE | Source: ALK Abello

ALK’s tree pollen tablet (ITULAZAX®) now recommended by NICE for use in the UK health system

ALK (ALKB:DC / OMX: ALK B) today announced that the National Institute for Health and Care Excellence (NICE) has recommended the use of the company’s tree pollen tablet ITULAZAX® for the treatment in...
18 juil. 2025 08h01 HE | Source: ALK Abello

EURneffy® godkendt som den første nålefri behandling af anafylaksi hos voksne og børn i Storbritannien

Intern viden ALK (ALKB:DC / OMX: ALK B) har i dag annonceret, at det britiske Medicines and Healthcare Products Regulatory Agency (MHRA) har godkendt EURneffy® 2 mg til behandling af anafylaksi hos...
18 juil. 2025 08h01 HE | Source: ALK Abello

EURneffy® approved as the first needle-free anaphylaxis treatment of adults and children in the UK

Inside Information ALK (ALKB:DC / OMX: ALK B) today announced that the Medicines and Healthcare Products Regulatory Agency (MHRA) has approved EURneffy® 2 mg in the United Kingdom (UK) for...
17 juil. 2025 03h00 HE | Source: European Academy of Allergy and Clinical Immunology

欧州アレルギー・臨床免疫学会 (EAACI) リーダー陣、2025年大会の記録的成功を振り返る：アレルギーおよび免疫学における転機

チューリッヒ発, July 17, 2025 (GLOBE NEWSWIRE) -- 7,600人以上の参加者を迎えた2025年欧州アレルギー・臨床免疫学会 (EAACI Congress 2025) は、その規模の大きさだけでなく、同学会のリーダー陣が発信した力強いメッセージによって注目を集めた。...
17 juil. 2025 03h00 HE | Source: European Academy of Allergy and Clinical Immunology

EAACI 領導團隊反思創紀錄的 2025 年大會：過敏與免疫學的關鍵時刻

蘇黎世, July 17, 2025 (GLOBE NEWSWIRE) -- 2025 年 EAACI 大會吸引了超過 7,600 名與會者，規模之大與領導團隊傳遞的強大訊息均引發熱議。在格拉斯哥大會落幕一個月後，EAACI 高層現在分享對這個專業領域的分水嶺有何見解。這場於 6 月13 日至 16...

Page suivante